EN
登录

“外科机器人之父”Fred Moll博士加入ForSight机器人董事会

“Father of Surgical Robotics” Dr. Fred Moll Joins ForSight Robotics Board of Directors

businesswire 等信源发布 2025-02-13 20:58

可切换为仅中文


YOKNEAM ILLIT, Israel--(

以色列约克奈姆·伊利--(

BUSINESS WIRE

商业热线

)--

)--

ForSight Robotics

ForSight机器人

, the pioneer in ophthalmic robotic surgery, announced today that Dr. Fred Moll, the founder of Intuitive Surgical, has joined its Board of Directors. Intuitive Surgical is the company behind the da Vinci surgical system, the first robotic surgical platform commercially available in the U.S. to be cleared by the FDA for use in general laparoscopic surgery.

眼科机器人手术的先驱弗雷德·摩尔博士今天宣布,直觉外科的创始人弗雷德·摩尔博士已加入其董事会。Intuitive Surgical是达芬奇手术系统背后的公司,达芬奇手术系统是美国第一个商业化的机器人手术平台,将被FDA批准用于普通腹腔镜手术。

His appointment to the Board of Directors marks his first advisor role for an ophthalmology-focused surgical robotics company..

他被任命为董事会成员,标志着他在一家专注于眼科的手术机器人公司担任第一任顾问。。

“Dr. Moll’s incredible legacy of pioneering the surgical robotics category perfectly aligns with our mission to transform the future of eye surgery,” said Dr. Joseph Nathan, ForSight Robotics’ co-founder, president, and Chief Medical Officer. “As we look to bring the ORYOM™ Platform, the world's first platform for fully robotic cataract surgery, to market, Dr.

ForSight robotics联合创始人、总裁兼首席医疗官约瑟夫·内森(JosephNathan)博士表示:“摩尔博士开创手术机器人领域的传奇与我们改变眼科手术未来的使命完美契合。”。“当我们期待将世界上第一个全机器人白内障手术平台ORYOM™平台推向市场时,Dr。

Moll’s unparalleled expertise will be instrumental in accelerating our growth and shaping ophthalmic innovation.”.

Moll无与伦比的专业知识将有助于加速我们的成长和塑造眼科创新。”。

A distinguished and prolific medical device entrepreneur, Dr. Moll brings decades of expertise to the ForSight Board. He founded Intuitive Surgical in the 1990s, pioneering robotic-assisted surgery and transforming minimally invasive procedures across dozens of specialties with its da Vinci robotic system.

Moll博士是一位杰出且多产的医疗器械企业家,为ForSight董事会带来了数十年的专业知识。他在20世纪90年代创立了直觉外科,开创了机器人辅助手术的先河,并通过达芬奇机器人系统在数十个专业领域改造了微创手术。

He then founded Auris Health, which was acquired by Johnson & Johnson in 2019. Most recently, he served as Chief Development Officer for J&J Medical Devices between 2019 and 2023. He has served on ForSight’s Strategic Advisory Board since the company’s founding in 2020 and is a current investor in ForSight Robotics..

然后,他成立了Auris Health,该公司于2019年被强生公司收购。最近,他在2019年至2023年间担任强生医疗器械的首席开发官。自2020年公司成立以来,他一直担任ForSight的战略顾问委员会成员,目前是ForSight Robotics的投资者。。

“Throughout my career, I have worked with medical robotics companies to improve healthcare access and outcomes for patients worldwide,” said Dr. Moll. “ForSight Robotics is advancing surgical robotics in eye care, helping to avoid preventable blindness and address the global shortage of ophthalmic surgeons.

Moll博士说:“在我的职业生涯中,我一直与医疗机器人公司合作,以改善全球患者的医疗服务和结果。”。“ForSight Robotics正在推进眼科手术机器人技术,帮助避免可预防的失明,解决全球眼科医生短缺的问题。

Having supported the company since its inception, I’m confident in its team, tools, and potential to reshape the industry. I’m proud to continue serving as a strategic advisor during this period of significant growth.”.

自从公司成立以来,我一直支持它,我对它的团队、工具和重塑行业的潜力充满信心。。

Dr. Moll’s appointment comes alongside the recent hiring of Yonatan Ushpizin as vice president of research and development and Ilanit Edri as vice president of people, reflecting ForSight’s strategic effort to expand its leadership team. Ushpizin brings nearly 20 years of experience leading multidisciplinary product development from concept to commercialization at companies like Medtronic, Mazor Robotics, and Meytar R&D.

Moll博士的任命是在最近聘请Yonatan Ushpizin担任研发副总裁和Ilanit Edri担任人力资源副总裁的同时进行的,这反映了ForSight扩大领导团队的战略努力。Ushpizin在美敦力(Medtronic)、马佐尔(Mazor Robotics)和梅塔尔(Meytar)研发公司拥有近20年的领导多学科产品开发经验,从概念到商业化。

Most recently, he served as Director of Robotics Research and Technology at Medtronic, where he played a key role in advancing robotics innovation. At ForSight, he will spearhead the next phase of the ORYOM™ Platform’s evolution as the company scales..

最近,他担任美敦力机器人研究与技术总监,在推动机器人技术创新方面发挥了关键作用。在ForSight,随着公司规模的扩大,他将引领ORYOM™平台下一阶段的发展。。

Edri brings over 25 years of experience in HR leadership roles within leading global organizations. Throughout her career, Ilanit has held key positions, such as Vice President of Human Resources at Elbit Systems (ISTAR Division) and VP of HR at The Open University of Israel. Additionally, she served as Head of HR for Teva Pharmaceuticals’ Global Generic R&D, for Tnuva Dairy, and for Medtronic Ventor.

Edri在领先的全球组织中拥有超过25年的人力资源领导经验。在她的职业生涯中,Ilanit担任过关键职位,例如Elbit Systems(ISTAR部门)人力资源副总裁和以色列开放大学人力资源副总裁。此外,她还担任Teva Pharmaceuticals全球通用研发、Tnuva Dairy和Medtronic Ventor的人力资源主管。

At ForSight, Edri will drive the company’s growth while cultivating a high-performance culture and aligning talent strategies with business objectives. Ushpizin and Edri are the first to hold these positions, underscoring a pivotal step in ForSight’s advancement and long-term vision..

在ForSight,Edri将推动公司的发展,同时培养高绩效文化,使人才战略与业务目标相一致。Ushpizin和Edri是第一个担任这些职位的人,强调了ForSight的进步和长期愿景的关键一步。。

“With the addition of Yonatan and Ilanit to our leadership team and the unparalleled guidance of Dr. Moll, ForSight is positioned to revolutionize ophthalmic surgery,” said Dr. Nathan. “Together, we are building a future where cutting-edge robotic surgery eradicates preventable blindness and sets new standards in surgical excellence; we are thrilled to lead the charge in transforming eye care worldwide.”.

Nathan博士说:“随着Yonatan和Ilanit加入我们的领导团队,以及Moll博士无与伦比的指导,ForSight将彻底改变眼科手术。”。“我们正在共同建设一个未来,在这个未来,尖端机器人手术可以根除可预防的失明,并为卓越的手术树立新的标准;我们很高兴能够领导全球眼科护理的变革。”。

About ForSight Robotics:

关于ForSight Robotics:

ForSight Robotics is a surgical robotics company pioneering world-class technology to democratize quality surgical eye care. The Israel-based company is developing the ORYOM

ForSight Robotics是一家外科机器人公司,开创了世界一流的技术,使优质外科眼科护理民主化。这家以色列公司正在开发ORYOM

TM

TM公司

Platform (“daylight” in Hebrew), the world’s first robotic surgery platform for cataracts and eye diseases, which will utilize AI-based algorithms, computer vision, and miniaturized-mechanics. Backed by globally-recognized VCs and industry leaders, ForSight is redefining ophthalmic surgery and bringing hope to millions of patients worldwide.

平台(希伯来语中的“日光”),世界上第一个用于白内障和眼疾的机器人手术平台,将利用基于AI的算法,计算机视觉和微型力学。在全球公认的风投公司和行业领袖的支持下,ForSight正在重新定义眼科手术,并为全球数百万患者带来希望。

Visit forsightrobotics.com and follow us on .

LinkedIn

LinkedIn

.

.